HTR4
Basic information
Region (hg38): 5:148446042-148677235
Links
Phenotypes
GenCC
Source:
ClinVar
This is a list of variants' phenotypes submitted to
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the HTR4 gene is commonly pathogenic or not.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
Variant type | Pathogenic | Likely pathogenic | VUS | Likely benign | Benign | Sum |
---|---|---|---|---|---|---|
synonymous | 1 | |||||
missense | 18 | 20 | ||||
nonsense | 0 | |||||
start loss | 0 | |||||
frameshift | 0 | |||||
inframe indel | 0 | |||||
splice donor/acceptor (+/-2bp) | 0 | |||||
splice region | 0 | |||||
non coding | 5 | |||||
Total | 0 | 0 | 20 | 2 | 4 |
Variants in HTR4
This is a list of pathogenic ClinVar variants found in the HTR4 region.
You can filter this list by clicking the number of variants in the Variants pathogenicity by type table.
Position | Type | Phenotype | Significance | ClinVar |
---|---|---|---|---|
5-148483241-T-G | not specified | Uncertain significance (Jul 20, 2021) | ||
5-148483255-C-T | Benign (Aug 04, 2018) | |||
5-148483280-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
5-148483286-C-T | not specified | Uncertain significance (May 03, 2023) | ||
5-148484289-T-C | Benign (Mar 30, 2018) | |||
5-148484353-A-G | not specified | Uncertain significance (Aug 17, 2021) | ||
5-148509245-G-T | Lung adenocarcinoma | Uncertain significance (Jun 06, 2022) | ||
5-148509464-A-G | Benign (Jun 12, 2018) | |||
5-148509465-T-C | not specified | Uncertain significance (Oct 02, 2023) | ||
5-148509570-C-T | not specified | Uncertain significance (Aug 02, 2021) | ||
5-148509587-C-G | not specified | Uncertain significance (Dec 19, 2023) | ||
5-148509745-T-C | not specified | Uncertain significance (Jun 22, 2024) | ||
5-148509783-C-T | not specified | Uncertain significance (Apr 05, 2023) | ||
5-148509792-C-T | not specified | Uncertain significance (Jan 30, 2024) | ||
5-148509823-C-T | not specified | Uncertain significance (Jan 18, 2022) | ||
5-148509888-A-T | not specified | Uncertain significance (Aug 13, 2021) | ||
5-148509891-C-T | not specified | Uncertain significance (Mar 31, 2023) | ||
5-148509908-C-T | not specified | Uncertain significance (Mar 15, 2024) | ||
5-148509939-A-G | not specified | Uncertain significance (Jan 03, 2024) | ||
5-148509954-G-A | not specified | Uncertain significance (Oct 12, 2022) | ||
5-148510001-C-G | not specified | Uncertain significance (Aug 30, 2022) | ||
5-148510014-C-T | not specified | Uncertain significance (Dec 11, 2023) | ||
5-148523291-G-T | not specified | Uncertain significance (Sep 29, 2023) | ||
5-148548816-C-T | not specified | Uncertain significance (Jun 11, 2021) | ||
5-148550194-A-G | not specified | Uncertain significance (Nov 18, 2023) |
GnomAD
Source:
Gene | Type | Bio Type | Transcript | Coding Exons | Length |
---|---|---|---|---|---|
HTR4 | protein_coding | protein_coding | ENST00000360693 | 7 | 226204 |
pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
---|---|---|---|---|---|---|
0.0247 | 0.973 | 125733 | 0 | 14 | 125747 | 0.0000557 |
Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
---|---|---|---|---|---|---|
Missense | 0.696 | 218 | 249 | 0.876 | 0.0000136 | 2792 |
Missense in Polyphen | 71 | 99.128 | 0.71624 | 1116 | ||
Synonymous | -0.229 | 102 | 99.1 | 1.03 | 0.00000599 | 853 |
Loss of Function | 2.65 | 6 | 18.2 | 0.330 | 8.57e-7 | 211 |
LoF frequencies by population
Ethnicity | Sum of pLOFs | p |
---|---|---|
African & African-American | 0.0000290 | 0.0000290 |
Ashkenazi Jewish | 0.00 | 0.00 |
East Asian | 0.000171 | 0.000163 |
Finnish | 0.00 | 0.00 |
European (Non-Finnish) | 0.000109 | 0.0000791 |
Middle Eastern | 0.000171 | 0.000163 |
South Asian | 0.0000327 | 0.0000327 |
Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: This is one of the several different receptors for 5- hydroxytryptamine (serotonin), a biogenic hormone that functions as a neurotransmitter, a hormone, and a mitogen. The activity of this receptor is mediated by G proteins that stimulate adenylate cyclase.;
- Pathway
- Serotonergic synapse - Homo sapiens (human);Calcium signaling pathway - Homo sapiens (human);cAMP signaling pathway - Homo sapiens (human);Neuroactive ligand-receptor interaction - Homo sapiens (human);Selective Serotonin Reuptake Inhibitor Pathway, Pharmacodynamics;Excitatory Neural Signalling Through 5-HTR 4 and Serotonin;GPCRs, Class A Rhodopsin-like;Monoamine GPCRs;Serotonin Receptor 4-6-7 and NR3C Signaling;Signaling by GPCR;Signal Transduction;G alpha (s) signalling events;Serotonin receptors;Amine ligand-binding receptors;Class A/1 (Rhodopsin-like receptors);GPCR ligand binding;GPCR downstream signalling
(Consensus)
Recessive Scores
- pRec
- 0.162
Intolerance Scores
- loftool
- 0.726
- rvis_EVS
- -0.05
- rvis_percentile_EVS
- 50.34
Haploinsufficiency Scores
- pHI
- 0.0902
- hipred
- Y
- hipred_score
- 0.729
- ghis
- 0.433
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- N
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- N
- gene_indispensability_score
- 0.327
Gene Damage Prediction
All | Recessive | Dominant | |
---|---|---|---|
Mendelian | Medium | Medium | Medium |
Primary Immunodeficiency | Medium | Medium | Medium |
Cancer | Medium | Medium | Medium |
Mouse Genome Informatics
- Gene name
- Htr4
- Phenotype
- adipose tissue phenotype (the observable morphological and physiological characteristics of mammalian fat tissue that are manifested through development and lifespan); growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype (the observable actions or reactions of mammalian organisms that are manifested through development and lifespan); mortality/aging (the observable characteristics related to the ability of a mammalian organism to live and age that are manifested throughout development and life span); nervous system phenotype (the observable morphological and physiological characteristics of the extensive, intricate network of electochemical structures in the body that is comprised of the brain, spinal cord, nerves, ganglia and parts of the receptor organs that are manifested through development and lifespan);
Gene ontology
- Biological process
- G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;chemical synaptic transmission;regulation of appetite;G protein-coupled serotonin receptor signaling pathway
- Cellular component
- cytoplasm;endosome;plasma membrane;integral component of plasma membrane;membrane;dendrite
- Molecular function
- G protein-coupled receptor activity;G protein-coupled serotonin receptor activity;neurotransmitter receptor activity